NeuBase Therapeutics

Accelerating the genetic revolution developing a new class of designer synthetic medicines.

HQ location

Pittsburgh, United States

Website

neubasetherapeutics.com

Launch date

2018–2024

Employees

Market cap

Enterprise value

$1m

Share price

$0.38 NBSE

Recent deals

https://twitter.com/neubaseinc https://www.linkedin.com/company/neubase-therapeutics

Authorizing premium user...